Skip to main content
ALUMIS INC. logo

ALUMIS INC. — Investor Relations & Filings

Ticker · ALMS ISIN · US0223071020 US Manufacturing
Filings indexed 210 across all filing types
Latest filing 2026-05-18 Annual Report
Country US United States of America
Listing US ALMS

About ALUMIS INC.

https://www.alumis.com/

Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for autoimmune and immune-mediated diseases. The company employs a precision medicine approach, leveraging a proprietary data analytics platform to advance its late-stage portfolio of next-generation targeted therapies. Alumis aims to replace broad immunosuppression with more specific treatments, seeking to optimize patient outcomes and address the limitations of existing therapies for a wide range of immune dysfunctions.

Recent filings

Filing Released Lang Actions
ARS
Annual Report
2026-05-18 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-18 English
DEF 14A
Proxy Solicitation & Information Statement
2026-05-18 English
10-Q
Interim / Quarterly Report
2026-05-14 English
8-K
Regulatory Filings
2026-05-14 English
8-K - ALUMIS INC. (0001847367) (Filer)
Regulatory Filings
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.